Maremmani, A.G.I.; Della Rocca, F.; Pacini, M.; Bacciardi, S.; Cimino, S.; Cerniglia, L.; Miccoli, M.; Maremmani, I.
Sodium Oxybate (SMO) as Part of Agonist Opioid Treatment in Alcohol–Heroin-Addicted Patients. J. Clin. Med. 2025, 14, 4016.
https://doi.org/10.3390/jcm14124016
AMA Style
Maremmani AGI, Della Rocca F, Pacini M, Bacciardi S, Cimino S, Cerniglia L, Miccoli M, Maremmani I.
Sodium Oxybate (SMO) as Part of Agonist Opioid Treatment in Alcohol–Heroin-Addicted Patients. Journal of Clinical Medicine. 2025; 14(12):4016.
https://doi.org/10.3390/jcm14124016
Chicago/Turabian Style
Maremmani, Angelo G. I., Filippo Della Rocca, Matteo Pacini, Silvia Bacciardi, Silvia Cimino, Luca Cerniglia, Mario Miccoli, and Icro Maremmani.
2025. "Sodium Oxybate (SMO) as Part of Agonist Opioid Treatment in Alcohol–Heroin-Addicted Patients" Journal of Clinical Medicine 14, no. 12: 4016.
https://doi.org/10.3390/jcm14124016
APA Style
Maremmani, A. G. I., Della Rocca, F., Pacini, M., Bacciardi, S., Cimino, S., Cerniglia, L., Miccoli, M., & Maremmani, I.
(2025). Sodium Oxybate (SMO) as Part of Agonist Opioid Treatment in Alcohol–Heroin-Addicted Patients. Journal of Clinical Medicine, 14(12), 4016.
https://doi.org/10.3390/jcm14124016
